Vanguard Capital Management
NVNO

Vanguard Capital Management’s enVVeno Medical NVNO Stock Holding History

Vanguard Capital Management’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.4K Hold
6,287
– – ﹤0.01% 3913
2026
Q1 		$63.7K Buy
+6,287
New +$68.8K ﹤0.01% 3893

Other funds holding NVNO

KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM

Vanguard Capital Management's NVNO Position: Q2 2026 in Review

Vanguard Capital Management held its enVVeno Medical (NVNO) position steady in Q2 2026 at 6,287 shares worth $67.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3913.

Vanguard Capital Management first reported a position in NVNO in Q1 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold NVNO as of Q2 2026.

  • Vanguard Capital Management held 6,287 shares of enVVeno Medical worth $67.4K as of Q2 2026.
  • Vanguard Capital Management left its enVVeno Medical share count unchanged in Q2 2026.
  • enVVeno Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3913 holding.
  • Vanguard Capital Management first reported a position in enVVeno Medical in Q1 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.